Jim Cramer Broke Down 16 Stocks Including Pharma Plays for Rising Oil
In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil.
Rigel Pharmaceuticals Inc (RIGL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 836,000 | $35,805,880 | +16% | 0.43% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 613,600 | $26,280,489 | +3% | 0.02% |
| 3. | Renaissance Technologies Jim Simons | 539,009 | $23,085,755 | +14% | 0.04% |
| 4. | Millennium Management Israel Englander | 431,460 | $18,479,432 | +310% | 0.01% |
| 5. | D E Shaw D. E. Shaw | 424,316 | $18,173,454 | +39% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 1,000,000 | $688,400.00 | 1,391,776 | 2022-06-09 | Filing | |
| $2.13 | 3,274 | $6,971.00 | 50,000 | 2019-05-22 | Filing | |
| $2.13 | 46,726 | $99,573.11 | 46,726 | 2019-05-22 | Filing | |
| $3.23 | 50,000 | $161,340.00 | 215,000 | 2018-09-11 | Filing | |
| $3.28 | 50,000 | $164,210.00 | 165,000 | 2018-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.36 | 4,000 | $145,440.00 | 12,722 | 2026-02-20 | Filing | |
| $21.93 | 1,734 | $38,019.68 | 57,235 | 2025-02-05 | Filing | |
| $20.92 | 2,036 | $42,595.16 | 58,969 | 2025-02-04 | Filing | |
| $21.93 | 1,796 | $39,379.10 | 51,704 | 2025-02-05 | Filing | |
| $20.92 | 2,125 | $44,457.13 | 53,500 | 2025-02-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 78,386 | $2,119,557 | 0.04% | |
| 2. | 2,916 | $78,849 | 0% | |
| 3. | 937 | $25,336 | 0% | |
| 4. | 752 | $20,680 | 0% | |
| 5. | 407 | $11,005 | 0% |
News See All
10 Best Performing Affordable Stocks Under $40
On January 14, Liz Ann Sonders from Charles Schwab appeared on a CNBC Television interview to discuss the market volatility, broadening out themes, and more.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Third Quarter 2025. [Operator Instructions] As a reminder, this conference is being recorded.
Voya Strengthens Position in Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is among the best low-priced growth stocks to buy now.
10 Best Low Priced Growth Stocks to Buy Now
One thing we know for sure: growth is everyone’s priority, and if that growth doesn’t come with a heavy price tag, that’s when the real game begins.
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)?
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the best affordable biotech stocks to invest in now. Rigel Pharmaceuticals, Inc.
12 Affordable Biotech Stocks to Invest In Now
On September 4, Mizuho healthcare strategist Jared Holz appeared on CNBC's ‘Power Lunch’ to talk about the changing sentiment in the healthcare sector, the differences in the biotech ETFs, and more...
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the top most undervalued biotech stocks to buy now. On August 6, analyst Joseph Pantginis from H.C.
10 Most Undervalued Biotech Stocks to Buy Now
On July 25, Salveen Richter, Goldman Sachs' lead biotech analyst, appeared on CNBC’s ‘Squawk Box’ to talk about the state of the biotech sector and what to expect from the earnings season, among...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Second Quarter 2025. [Operator Instructions] As a reminder, this conference is being recorded.
Hedge Fund Resource Center